References
- Han J, Jia Y, Takeda K, Shiraishi Y, Okamoto M, Dakhama A, Gelfand EW. Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus. Am J Respir Crit Care Med. 2010;182(4):455–463. doi:https://doi.org/10.1164/rccm.200912-1811OC.
- Kloepfer KM, DeMore JP, Vrtis RF, Swenson CA, Gaworski KL, Bork JA, Evans MD, Gern JE. Effects of montelukast on patients with asthma after experimental inoculation with human rhinovirus 16. Ann Allergy Asthma Immunol. 2011;106(3):252–257. doi:https://doi.org/10.1016/j.anai.2010.11.021.
- Crimi N, Pagano C, Palermo F, Mastruzzo C, Prosperini G, Pistorio MP, Vancheri C. Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin A-induced bronchoconstriction. J Allergy Clin Immunol. 2003;111(4):833–839. doi:https://doi.org/10.1067/mai.2003.161.
- Fitzgerald DA, Mellis CM. Leukotriene receptor antagonists in virus-induced wheezing: evidence to date. Treat Respir Med. 2006;5(6):407–417. doi:https://doi.org/10.2165/00151829-200605060-00006.
- Peng WS, Chen X, Yang XY, Liu EM. Systematic review of Montelukast's efficacy for preventing post-bronchiolitis wheezing. Pediatr Allergy Immunol. 2014;25(2):143–150. doi:https://doi.org/10.1111/pai.12124.
- Bisgaard H. Montelukast in RSV-bronchiolitis. Am J Respir Crit Care Med. 2004;169(4):542–543. doi:https://doi.org/10.1164/ajrccm.169.4.952.
- Bozek A, Warkocka-Szoltysek B, Filipowska-Gronska A, Jarzab J. Montelukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patients. J Asthma. 2012;49(5):530–534. doi:https://doi.org/10.3109/02770903.2012.680638.